$390 Million is the total value of Parkman Healthcare Partners LLC's 83 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 39.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DXCM | Buy | DEXCOM INC | $15,354,000 | +26.0% | 41,528 | +40.4% | 3.93% | +21.9% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $12,853,000 | -30.2% | 175,712 | -25.8% | 3.29% | -32.4% |
| VCEL | Sell | VERICEL CORP | $12,375,000 | +48.3% | 400,743 | -11.0% | 3.17% | +43.5% |
| SDGR | Buy | SCHRODINGER INC | $12,359,000 | +420.2% | 156,085 | +212.2% | 3.17% | +403.3% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $12,133,000 | +156.2% | 1,875,336 | +1.8% | 3.11% | +147.9% |
| NTRA | Sell | NATERA INC | $12,029,000 | -4.9% | 120,867 | -31.0% | 3.08% | -8.0% |
| DHR | Sell | DANAHER CORPORATION | $10,593,000 | -24.3% | 47,687 | -26.6% | 2.71% | -26.8% |
| IQV | Buy | IQVIA HLDGS INC | $10,432,000 | +26.0% | 58,224 | +10.9% | 2.67% | +21.9% |
| HUM | Sell | HUMANA INC | $10,178,000 | -7.2% | 24,808 | -6.4% | 2.61% | -10.2% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $9,911,000 | +9.4% | 39,666 | -0.8% | 2.54% | +5.8% |
| ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $9,758,000 | +277.6% | 127,171 | +112.0% | 2.50% | +265.5% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $9,414,000 | +93.4% | 81,573 | +63.1% | 2.41% | +87.1% |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $9,019,000 | +32.3% | 617,722 | +28.6% | 2.31% | +28.0% |
| CTLT | Sell | CATALENT INC | $8,754,000 | +13.5% | 84,119 | -6.6% | 2.24% | +9.8% |
| CDMO | Buy | AVID BIOSERVICES INC | $8,649,000 | +134.4% | 749,511 | +54.8% | 2.22% | +126.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $8,414,000 | +28.5% | 23,993 | +14.2% | 2.16% | +24.3% |
| PODD | Sell | INSULET CORP | $7,819,000 | +1.7% | 30,587 | -5.9% | 2.00% | -1.6% |
| KOD | Sell | KODIAK SCIENCES INC | $7,333,000 | +33.5% | 49,913 | -46.2% | 1.88% | +29.2% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $7,303,000 | +24.6% | 331,513 | +1.7% | 1.87% | +20.6% |
| ATEC | Buy | ALPHATEC HLDGS INC | $7,299,000 | +143.4% | 502,655 | +11.3% | 1.87% | +135.5% |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $7,235,000 | -24.9% | 59,377 | -46.2% | 1.85% | -27.4% |
| ICAD | Sell | ICAD INC | $7,162,000 | +39.7% | 542,602 | -6.7% | 1.84% | +35.2% |
| XLRN | Buy | ACCELERON PHARMA INC | $6,711,000 | +19.2% | 52,458 | +4.9% | 1.72% | +15.4% |
| SPNE | Buy | SEASPINE HLDGS CORP | $6,543,000 | +24.1% | 374,945 | +1.7% | 1.68% | +20.1% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $6,016,000 | +49.3% | 231,758 | -1.4% | 1.54% | +44.4% |
| STRO | Buy | SUTRO BIOPHARMA INC | $5,789,000 | +174.2% | 266,645 | +27.0% | 1.48% | +165.3% |
| IMUX | Sell | IMMUNIC INC | $5,607,000 | -24.5% | 366,691 | -8.3% | 1.44% | -26.9% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $5,607,000 | -2.2% | 282,327 | +0.6% | 1.44% | -5.4% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $5,563,000 | +8.1% | 361,689 | -22.2% | 1.42% | +4.5% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $5,415,000 | +91.8% | 76,143 | +1.2% | 1.39% | +85.7% |
| NUAN | Sell | NUANCE COMMUNICATIONS INC | $5,100,000 | -4.0% | 115,662 | -27.7% | 1.31% | -7.1% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $4,700,000 | +4.6% | 36,161 | +17.2% | 1.20% | +1.2% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $4,615,000 | -52.8% | 50,584 | -58.7% | 1.18% | -54.4% |
| INFU | Buy | INFUSYSTEM HLDGS INC | $4,536,000 | +51.9% | 241,511 | +3.7% | 1.16% | +46.9% |
| SILK | Sell | SILK RD MED INC | $4,273,000 | -47.0% | 67,854 | -43.5% | 1.10% | -48.7% |
| IONS | New | IONIS PHARMACEUTICALS INC | $4,264,000 | – | 75,418 | +100.0% | 1.09% | – |
| AVTR | New | AVANTOR INC | $4,247,000 | – | 150,872 | +100.0% | 1.09% | – |
| KRMD | Buy | REPRO MED SYS INC | $4,222,000 | -7.4% | 701,259 | +11.1% | 1.08% | -10.4% |
| AXGN | Buy | AXOGEN INC | $4,126,000 | +183.8% | 230,509 | +84.4% | 1.06% | +174.5% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $4,011,000 | +45.8% | 538,370 | -32.8% | 1.03% | +41.2% |
| KDMN | Buy | KADMON HLDGS INC | $3,878,000 | +13.0% | 934,364 | +6.8% | 0.99% | +9.5% |
| NVAX | Buy | NOVAVAX INC | $3,847,000 | +102.9% | 34,498 | +97.1% | 0.99% | +96.4% |
| IDXX | Buy | IDEXX LABS INC | $3,796,000 | +28.8% | 7,593 | +1.2% | 0.97% | +24.6% |
| GOSS | New | GOSSAMER BIO INC | $3,392,000 | – | 350,779 | +100.0% | 0.87% | – |
| STXS | Buy | STEREOTAXIS INC | $3,296,000 | +43.0% | 647,543 | +0.6% | 0.84% | +38.4% |
| ONEM | New | 1LIFE HEALTHCARE INC | $3,274,000 | – | 75,000 | +100.0% | 0.84% | – |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $3,274,000 | +25.5% | 123,031 | -12.2% | 0.84% | +21.4% |
| HCAT | New | HEALTH CATALYST INC | $3,265,000 | – | 75,000 | +100.0% | 0.84% | – |
| ABBV | Sell | ABBVIE INC | $3,215,000 | -51.1% | 30,000 | -60.0% | 0.82% | -52.6% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $3,093,000 | – | 110,276 | +100.0% | 0.79% | – |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $2,843,000 | +36.9% | 21,609 | -47.4% | 0.73% | +32.4% |
| IMVT | Sell | IMMUNOVANT INC | $2,807,000 | -46.9% | 60,781 | -59.5% | 0.72% | -48.6% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $2,506,000 | +0.5% | 30,758 | -12.1% | 0.64% | -2.7% |
| Sell | TRILLIUM THERAPEUTICS INC | $2,421,000 | -54.6% | 164,585 | -56.1% | 0.62% | -56.1% | |
| ETNB | Sell | 89BIO INC | $2,356,000 | -16.5% | 96,673 | -12.1% | 0.60% | -19.1% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $2,192,000 | – | 25,000 | +100.0% | 0.56% | – |
| SDC | Sell | SMILEDIRECTCLUB INC | $2,098,000 | -50.1% | 175,691 | -51.2% | 0.54% | -51.7% |
| BCEL | Buy | ATRECA INC | $2,039,000 | +317.0% | 126,258 | +260.7% | 0.52% | +304.7% |
| KALA | Sell | KALA PHARMACEUTICALS INC | $1,847,000 | -20.6% | 272,445 | -12.1% | 0.47% | -23.2% |
| ONCT | New | ONCTERNAL THERAPEUTICS INC | $1,846,000 | – | 376,779 | +100.0% | 0.47% | – |
| AVRO | Sell | AVROBIO INC | $1,687,000 | -19.3% | 121,018 | -24.7% | 0.43% | -22.0% |
| SURF | Sell | SURFACE ONCOLOGY INC | $1,624,000 | +17.7% | 175,792 | -12.1% | 0.42% | +14.0% |
| OM | Buy | OUTSET MED INC | $1,604,000 | +358.3% | 28,211 | +303.0% | 0.41% | +341.9% |
| CRIS | New | CURIS INC | $1,597,000 | – | 195,000 | +100.0% | 0.41% | – |
| CSTL | Sell | CASTLE BIOSCIENCES INC | $1,533,000 | -0.7% | 22,831 | -23.9% | 0.39% | -3.9% |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $1,503,000 | -48.6% | 160,112 | -40.2% | 0.38% | -50.3% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $1,443,000 | -33.3% | 12,976 | -28.7% | 0.37% | -35.3% |
| NEPH | Sell | NEPHROS INC | $1,433,000 | -17.9% | 167,048 | -30.8% | 0.37% | -20.6% |
| PROF | Sell | PROFOUND MED CORP | $1,420,000 | +15.0% | 69,049 | -1.4% | 0.36% | +11.3% |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $1,325,000 | – | 75,000 | +100.0% | 0.34% | – |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $1,238,000 | -35.5% | 89,503 | -31.3% | 0.32% | -37.6% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $1,194,000 | +33.3% | 189,161 | -9.3% | 0.31% | +29.1% |
| FBRX | Buy | FORTE BIOSCIENCES INC | $1,132,000 | +86.8% | 31,098 | +148.8% | 0.29% | +81.2% |
| ALT | New | ALTIMMUNE INC | $1,128,000 | – | 100,000 | +100.0% | 0.29% | – |
| BLRX | New | BIOLINERX LTDsponsored ads | $1,078,000 | – | 427,943 | +100.0% | 0.28% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $698,000 | +57.6% | 31,386 | +4.6% | 0.18% | +53.0% |
| FATE | New | FATE THERAPEUTICS INC | $692,000 | – | 7,615 | +100.0% | 0.18% | – |
| EDAP | Buy | EDAP TMS S Asponsored adr | $672,000 | +16.9% | 129,889 | +3.9% | 0.17% | +13.2% |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $636,000 | – | 50,290 | +100.0% | 0.16% | – |
| VSTM | New | VERASTEM INC | $536,000 | – | 251,449 | +100.0% | 0.14% | – |
| RAPT | Sell | RAPT THERAPEUTICS INC | $497,000 | -48.6% | 25,177 | -16.1% | 0.13% | -50.4% |
| PHAS | New | PHASEBIO PHARMACEUTICALS INC | $371,000 | – | 110,547 | +100.0% | 0.10% | – |
| ARPO | Sell | AERPIO PHARMACEUTICALS INC | $259,000 | -42.4% | 264,382 | -11.9% | 0.07% | -44.5% |
| APRE | Exit | APREA THERAPEUTICS INC | $0 | – | -20,042 | -100.0% | -0.13% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -116,158 | -100.0% | -0.13% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -10,000 | -100.0% | -0.15% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -351,230 | -100.0% | -0.18% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -200,000 | -100.0% | -0.23% | – |
| Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -145,501 | -100.0% | -0.24% | – | |
| QDEL | Exit | QUIDEL CORP | $0 | – | -5,001 | -100.0% | -0.29% | – |
| INOV | Exit | INOVALON HLDGS INC | $0 | – | -50,000 | -100.0% | -0.35% | – |
| MSON | Exit | MISONIX INC | $0 | – | -135,596 | -100.0% | -0.42% | – |
| MGTX | Exit | MEIRAGTX HLDGS PLC | $0 | – | -130,763 | -100.0% | -0.46% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -85,000 | -100.0% | -1.05% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -1.52% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -22,501 | -100.0% | -1.62% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -35,000 | -100.0% | -2.19% | – |
| AXNX | Exit | AXONICS MODULATION TECHNOLOG | $0 | – | -176,950 | -100.0% | -2.39% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -125,834 | -100.0% | -2.76% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -132,544 | -100.0% | -3.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.